What is the benefit of treatment with multiple lines of chemotherapy for patients with metastatic br...
What is the benefit of treatment with multiple lines of chemotherapy for patients with metastatic breast cancer? A retrospective cohort study
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • More than 30% of the metastatic breast cancer patients treated with chemotherapy receive more than five treatment lines. • Preferred chemotherapies were anthracycline, taxanes, capecitabine and vinorelbine. • In our data benefit of the treatment is independent from prior treatment outcome. • Clinical judgement tool or predictive biomar...
Alternative Titles
Full title
What is the benefit of treatment with multiple lines of chemotherapy for patients with metastatic breast cancer? A retrospective cohort study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1749616574
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1749616574
Other Identifiers
ISSN
1877-7821
E-ISSN
1877-783X
DOI
10.1016/j.canep.2015.09.010
